Violations of Exhibiting and FDA Rules at an American Psychiatric Association Annual Meeting-Reference-Cited by-同舟云学术

Violations of Exhibiting and FDA Rules at an American Psychiatric Association Annual Meeting

Published:2005-12 Issue:4 Volume:26 Page:389-399
ISSN:0197-5897
Container-title:Journal of Public Health Policy
language:en
Short-container-title:J Public Health Pol

Author:

Lurie Peter,Tran Tung,Wolfe Sidney Manuel,Goodman Robert

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://link.springer.com/content/pdf/10.1057/palgrave.jphp.3200049.pdf

Reference23 articles.

1. Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals. Available at http://www.phrma.org/publications/policy//2004-01-19.391.pdf , accessed 30 March, 2005.

2. Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med. 1996;11:575–583.

3. Food and Drug Administration. In the summer of 2001, the Food and Drug Administration issued 14 Warning Letters for improper promotional activity at medical meetings. Available at http://www.fda.gov/cder/warn/warn2001.htm , accessed 30 March 2005.

4. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551–557.

5. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest. 1992;102:270–274.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Professional Societies and Commercial Conflicts of Interest;Annals of Emergency Medicine;2012-02

2. Off-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech;American Journal of Law & Medicine;2011-06

3. Conflicts of Interest;Ethics in Psychiatry;2010

4. Some ethical concerns about counselling research;Counselling Psychology Quarterly;2009-09

5. Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals;New England Journal of Medicine;2009-04-09